Literature DB >> 20528929

Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.

Nivedita Roy1, Soumik Barman, Amit Ghosh, Amit Pal, Krishnendu Chakraborty, Santa Sabuj Das, Dhira Rani Saha, Shinji Yamasaki, Hemanta Koley.   

Abstract

We show here that oral immunization with purified outer membrane vesicles (OMVs) of Vibrio cholerae induces a prolonged high rise in the protective antibody titre. Rabbit immune sera were vibriocidal against the homologous and against several heterologous V. cholerae strains in vitro. In addition, OMV immunization conferred significant protective immunity against subsequent bacterial challenges. Thirty OMV-immunized rabbits were challenged with different V. cholerae strains; each challenged group contained five immunized and three unimmunized animals. All the immunized rabbits survived bacterial challenges and were healthy after 24 h, except the two from each group that received the SG24 and SG06 strains, respectively, which developed watery diarrhoea. In contrast, all the unimmunized animals developed cholera-like symptoms, with a death toll of eight within 24 h of challenge. This is the first report of the induction of protective immunity by V. cholerae OMVs in a rabbit model (removable intestinal tie-adult rabbit diarrhoea) that mimics the human disease. Finally, OMVs were found to be significantly less reactogenic than the live and the heat-killed bacteria. Our studies show that oral immunization with OMVs of V. cholerae may induce long-term immunity and may be useful as a 'nonliving' vaccine candidate for the future.
© 2010 NICED. Journal compilation © 2010 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528929     DOI: 10.1111/j.1574-695X.2010.00692.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  16 in total

Review 1.  Bacterial outer membrane vesicles in disease and preventive medicine.

Authors:  Can M Unal; Viveka Schaar; Kristian Riesbeck
Journal:  Semin Immunopathol       Date:  2010-12-12       Impact factor: 9.623

2.  Proteomic analysis of Vibrio cholerae outer membrane vesicles.

Authors:  Emrah Altindis; Yang Fu; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

3.  Bacterial Outer Membrane Vesicles Provide Broad-Spectrum Protection against Influenza Virus Infection via Recruitment and Activation of Macrophages.

Authors:  Eun-Hye Bae; Sang Hwan Seo; Chang-Ung Kim; Min Seong Jang; Min-Suk Song; Tae-Young Lee; Yu-Jin Jeong; Moo-Seung Lee; Jong-Hwan Park; Pureum Lee; Young Sang Kim; Sang-Hyun Kim; Doo-Jin Kim
Journal:  J Innate Immun       Date:  2019-03-07       Impact factor: 7.349

Review 4.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

5.  Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.

Authors:  Qiong Liu; Qing Liu; Jie Yi; Kang Liang; Tian Liu; Kenneth L Roland; Yanlong Jiang; Qingke Kong
Journal:  Int J Med Microbiol       Date:  2016-08-25       Impact factor: 3.473

Review 6.  Prophylactic vaccine delivery systems against epidemic infectious diseases.

Authors:  Chao Pan; Hua Yue; Li Zhu; Guang-Hui Ma; Heng-Liang Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-07-17       Impact factor: 17.873

7.  Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.

Authors:  Bas van de Waterbeemd; Gijsbert Zomer; Patricia Kaaijk; Nicole Ruiterkamp; René H Wijffels; Germie P J M van den Dobbelsteen; Leo A van der Pol
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro.

Authors:  Erika Bartolini; Elvira Ianni; Elisabetta Frigimelica; Roberto Petracca; Giuliano Galli; Francesco Berlanda Scorza; Nathalie Norais; Donatello Laera; Fabiola Giusti; Andrea Pierleoni; Manuela Donati; Roberto Cevenini; Oretta Finco; Guido Grandi; Renata Grifantini
Journal:  J Extracell Vesicles       Date:  2013-05-06

9.  Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen.

Authors:  Laura Fantappiè; Micaela de Santis; Emiliano Chiarot; Filippo Carboni; Giuliano Bensi; Olivier Jousson; Immaculada Margarit; Guido Grandi
Journal:  J Extracell Vesicles       Date:  2014-08-11

10.  IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant Rates.

Authors:  Anna E Schager; C Coral Dominguez-Medina; Francesca Necchi; Francesca Micoli; Yun Shan Goh; Margaret Goodall; Adriana Flores-Langarica; Saeeda Bobat; Charlotte N L Cook; Melissa Arcuri; Arianna Marini; Lloyd D W King; Faye C Morris; Graham Anderson; Kai-Michael Toellner; Ian R Henderson; Constantino López-Macías; Calman A MacLennan; Adam F Cunningham
Journal:  mBio       Date:  2018-03-06       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.